Peptide Therapy
Safety profiles, monitoring requirements, and risk assessment across peptide compounds.
Evidence-based guide to metformin dosing in CKD patients. eGFR cutoffs, lactic acidosis risk, FDA label changes, and how longevity physicians adjust protocol for renal impairment.
A physician's guide to NAD+ IV therapy contraindications — cancer history, active infections, G6PD deficiency, cardiac conditions, and pregnancy.
A physician's guide to chelation therapy safety — covering EDTA, DMPS, and DMSA risks, contraindications, mineral depletion, and clinical monitoring protocols.
A clinical breakdown of ozone therapy risks by administration route, contraindications, and how to evaluate whether ozone treatment is appropriate for you.
A physician's guide to NAD+ IV therapy side effects: what causes them, which are common vs serious, how to minimize discomfort, and who should avoid treatment.
Honest physician's answer about FDA approval for peptide therapy. Which peptides are approved, which are investigational, off-label use, and the European regulatory landscape.
Honest physician assessment of BPC-157 side effects, contraindications, FDA status, and what patients report. Evidence levels clearly distinguished.
Complete guide to chelation therapy side effects. Common reactions, serious risks, mineral depletion, monitoring requirements, and how to minimize adverse effects.
What to expect during and after PEMF therapy — common responses, contraindications, how to titrate sessions, and when temporary symptom increases are normal.
Pentosan polysulfate maculopathy explained by Dr. Julian Douwes. Retinal toxicity risk, screening guidelines, reversibility questions, and what every PPS user must know.
Honest assessment of BPC-157 side effects, safety data, FDA warnings, and theoretical risks. What we know, what we don't, and what to watch for.
Honest assessment of TB-500 side effects, WADA ban context, theoretical risks, and what clinical experience shows about Thymosin Beta-4 safety.
Step-by-step guide to subcutaneous peptide injection. Equipment, reconstitution, injection sites, rotation, storage, and sterility from a physician's perspective.
Dihexa safety analysis by Dr. Julian Douwes. The HGF/c-Met oncogenic pathway concern, retracted research, failed clinical trials, and what patients must understand.
Comprehensive guide to peptide therapy safety. Regulatory status, quality concerns, side effects, contraindications, and why physician oversight matters.
